Clinical Trials Browser

Burkitt Lymphoma, Lymphoma, Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Lymphoma, Large-Cell, Immunoblastic, Lymphoma, Large B-Cell, Diffuse, Lymphoma, Large-Cell, Anaplastic, Lymphoma, B-Cell, Marginal Zone, Lymphoma, Mantle-Cell

NCT07118800 2025-08-12

NACRE-2

Phase 3 Not yet recruiting

160 enrolled

Tumor-Agnostic

Adenocarcinoma

NCT06841172 2025-08-01

Continuation of First-line Therapy With Radiotherapy Versus Early Switch to Second-line Therapy in Oligoprogressive HCC

Phase 3 Recruiting

132 enrolled

Gastrointestinal

Carcinoma, Hepatocellular

NCT04175210 2025-07-25

PRART

Phase 3 Active not recruiting

400 enrolled

Breast

Breast Neoplasms

NCT06960707 2025-07-25

PRATO

Phase 3 Recruiting

400 enrolled

Breast

Breast Neoplasms

NCT05448547 2025-07-01

GrandP/SPCG19

Phase 3 Recruiting

980 enrolled

Genitourinary

Prostatic Neoplasms

NCT06625970 2025-06-26

PEACE 7

Phase 3 Recruiting

700 enrolled

Genitourinary

Prostatic Neoplasms

NCT07020247 2025-06-13

Personalized Long-course Radiotherapy Plus Chemotherapy With or Without Immunotherapy for LARC: PALACE Study

Phase 3 Recruiting

184 enrolled

Gastrointestinal

Locally Advanced Rectal Cancer (LARC)

Clinical Trials

STABLE-MATES

SPECTRO GLIO

Two Studies for Patients With Unfavorable Intermediate Risk Prostate Cancer Testing Less Intense Treatment for Patients With a Low Gene Risk Score and Testing a More Intense Treatment for Patients With a Higher Gene Risk Score, The Guidance Trial

LAP100

HOPE

Reduced-dose vs Standard-dose Irradiation for Low-risk Clinical Target Volume in Nasopharyngeal Carcinoma.

Radiation Therapy With Protons or Photons in Treating Patients With Liver Cancer

Two Studies for Patients With High Risk Prostate Cancer Testing Less Intense Treatment for Patients With a Low Gene Risk Score and Testing a More Intense Treatment for Patients With a High Gene Risk Score, The PREDICT-RT Trial

Nivolumab and Ipilimumab With or Without Local Consolidation Therapy in Treating Patients With Stage IV Non-Small Cell Lung Cancer

IC Plus Low-dose Radiation Plus Cadonilimab in LANPC

RADVAN

Hypofractionated Radiation Therapy or Conventional Radiation Therapy After Surgery in Treating Patients With Prostate Cancer

Temporally-Modulated Pulsed Radiation Therapy Versus Standard Radiation Therapy for the Treatment of Newly Diagnosed, IDH Wildtype, MGMT-Unmethylated Glioblastoma

Postoperative Radiotherapy Combined With Nimotuzumab Followed by Bemcentinib in High-Risk Patients With Head and Neck Squamous Cell Carcinoma

RePaIr-HN

Adjuvant Radiotherapy in High Risk Locally Advanced DTC

NIRVANA-LUNG

Hypofractionated Radiation Therapy After Mastectomy in Preventing Recurrence in Patients With Stage IIa-IIIa Breast Cancer

REVELUTION-2: Relugolix+Abiraterone Acetate (AA) Versus Leuprolide+AA Cardiac Trial

PH Weighted Chemical Exchange Saturation Transfer MRI-Based Surgical Resection to Improve Survival in Patients With Glioblastoma

BEFORE

05-001: Treatment of Acute Lymphoblastic Leukemia in Children

OLIGAMI

CCRT Followed by PD-1 Inhibitor Maintenance Therapy in Locally Advanced ESCC

BIOMEDE 2

ImproveCodel

POLO

Sintilimab Plus Chemotherapy as Neoadjuvant and Adjuvant Treatment for Locally Advanced Oral Squamous Cell Carcinoma

Radiation Therapy With Concomitant and Adjuvant Temozolomide Versus Radiation Therapy With Adjuvant PCV Chemotherapy in Patients With Anaplastic Glioma or Low Grade Glioma

Chemoradiotherapy in Esophageal or Esophagogastric Junction Cancer

Testing the Addition of the Drug Apalutamide to the Usual Hormone Therapy and Radiation Therapy After Surgery for Prostate Cancer, INNOVATE Trial

Randomized Study of Hypofractionated and Conventional Fractionation Radiotherapy After Breast Conservative Surgery

Reduced-dose Versus Conventional-dose Intensity-modulated Radiation Therapy for Locally Advanced Nasopharyngeal Carcinoma With Remission After Induction Chemotherapy and Immunotherapy

Neo-Margin

Head and Neck Cancer Study Project in the Geriatric Population

FIL_GAZEBO

TRAIN

UPFRONT-NECK

Conventional or Hypofractionated Radiation Therapy in Treating Patients With Prostate Cancer

Adjuvant Radiotherapy of Sintilimab Versus TACE for HCC

SALTORL

KANALRAD

Rituximab and Combination Chemotherapy With or Without Radiation Therapy in Treating Patients With B-Cell Non-Hodgkin's Lymphoma

NACRE-2

Continuation of First-line Therapy With Radiotherapy Versus Early Switch to Second-line Therapy in Oligoprogressive HCC

PRART

PRATO

GrandP/SPCG19

PEACE 7

Personalized Long-course Radiotherapy Plus Chemotherapy With or Without Immunotherapy for LARC: PALACE Study